查詢結果分析
來源資料
相關文獻
- Risk Factors for New-onset Cardiac Events in Patients with Rheumatoid Arthritis: Cardioprotective Effects of Methotrexate and Tumor Necrosis Factor Antagonist
- Detection of Tumor Necrosis Factor-α and Receptors in the Serum and Synovial Fluid of Patients With Rheumatoid Arthritis and Osteoarthritis
- 抗腫瘤壞死因子藥物與類風濕性關節炎
- 抗腫瘤壞死因子製劑(Anti-TNF)
- 生物製劑在類風濕性關節炎之治療
- Taiwan Experience with Etanercept in Juvenile Rheumatoid Arthritis
- 免疫生物製劑對結核病、B型與C型病毒肝炎活化之影響
- The Value of Plasma Levels of Tumor Necrosis Factor-α and Interleukin-6 in Predicting the Severity and Prognosis in Patients with Congestive Heart Failure
- Discontinuation and Adverse Events or Events of Etanercept Treatment in Patients with Rheumatoid Arthritis
- Estimated Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Rheumatic Diseases Treated with Tumor Necrosis Factor Blockers
頁籤選單縮合
題名 | Risk Factors for New-onset Cardiac Events in Patients with Rheumatoid Arthritis: Cardioprotective Effects of Methotrexate and Tumor Necrosis Factor Antagonist=類風濕性關節炎病人新發生心臟事件的危險因子:Methotrexate和腫瘤壞死因子拮抗劑的心臟保護效果 |
---|---|
作者姓名(中文) | 陳昭宇; 陳宏安; 陳明瀚; 林永章; 林峻宇; 陳之盛; 廖顯宗; 周昌德; 翁世蜂; 褚錦承; 王志中; 劉津秀; 陳俊雄; | 書刊名 | 中華民國風濕病雜誌 |
卷期 | 30:1 2016.09[民105.09] |
頁次 | 頁33-42 |
分類號 | 415.695 |
關鍵詞 | 心臟; 類風濕性關節炎; 腫瘤壞死因子; Heart; Methotrexate; Rheumatoid arthritis; Tumor necrosis factor; |
語文 | 英文(English) |